Lundbeckfond Invest A/S 13D and 13G filings for Lexeo Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:49 pm Sale | 2024-09-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Lundbeckfond Invest A/S | 942,671 2.900% | -893,288 (-48.66%) | Filing |
| 2024-02-14 4:34 pm Purchase | 2023-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Lundbeckfond Invest A/S | 1,835,959 6.900% | 1,835,959 (New Position) | Filing |